1. Requirement 1: a stable liquid vaccine, including live poultry virus, 5-40% (P / V) sugar alcohol, 0.15-0.75 m amino acids (arginin, glutam and glizina) and a stable liquid vaccine with pH value of 6.0-8.0； live poultry virus 1. Select from a population consisting of a attenuated virus, a recombinant fowl virus vector and a attenuated fowl virus recombinant vector；In this case, a hetero antigen can also be encoded by the re matched poultry virus vector or the re matched virus vector obtained from the reduced poultry virus. Item 2: stable liquid item 1 requires a vaccine in which sugar is adsorbed. 13. Claim 3: the stable solution vaccine of claim 2, wherein the amino acid is argon. 4. Claim 4: liquid stable vaccine of claim 3, in which live poultry virus is selected from a poultry bronchitis virus (IBV),Infectious mumps virus (IBDV),Newcastle disease virus (NDV)Marek's disease virus (MDV),metapneumovirus aviar (aMPV)Turkey herpesvirus (HVT)And any combination of them Claim 18: liquid stabilized vaccine of claim 4, which also includes bacteria. Claim 19: liquid stable vaccine for claim 18, in which bacteria are selected as bioaugmentation Pasteurella multocida, live attenuated Salmonella, live attenuated Vibrio, live attenuated gallisepricum, live carrier and any combination thereof It's them. Claim 21: a method of vaccination against the non infectious bronchitis virus (IBV),Infertile bursitis (IBDV) virusNewcastle disease virus (NDV)Marek's disease virus (MDV),An avian metabolic virus (aMPV) or a turkey herpesvirus (HVT),This includes the provision of liquid stable vaccines as required by No. 17 to poultry. Claim 22: the method of claim 21, which is such management by subcutaneous injection. Claim 23: a method of vaccinating birds against the virus, including liquid stable vaccinations of birds in claim 1. Claim 24: claimed method 23Requirement 25: a method of producing a stable liquid vaccine comprising a reduced live poultry virus combined with 5-40% (P / V) s
